TABLE 2.

Anti-TB medication (n = 80)

Medication	No. (%) of patients
Fluoroquinolones
Levofloxacin	21 (26.3)
Moxifloxacin	57 (71.3)
Second-line injectable agents
Amikacin	54 (67.5)
Kanamycin	25 (31.3)
Both amikacin and kanamycin	1 (1.3)
Capreomycin	2 (2.5)
Other core second-line agents
Linezolid	62 (77.5)
Protionamide	52 (65.0)
Clofazimine	64 (80.0)
Cycloserine	8 (10.0)
Add-on agents (D1)
Pyrazinamide	32 (40.0)
Ethambutol	58 (72.5)
Add-on agents (D3)
Thioacetazone	7 (8.8)
Others/not classified
Rifabutin	11 (13.8)
Clarithromycin	11 (13.8)
Azithromycin	3 (3.8)
Co-trimoxazole	7 (8.8)
Ciprofloxacin	4 (5.0)
Ertapenem	7 (8.8)